香港股市 已收市

Shanghai Haohai Biological Technology Co., Ltd. (5HB.F)

Frankfurt - Frankfurt 延遲價格。貨幣為 EUR。
加入追蹤清單
3.7200-0.0200 (-0.53%)
市場開市。 截至 08:20AM CEST。

Shanghai Haohai Biological Technology Co., Ltd.

WenGuang Plaza
23rd Floor No. 1386, Hongqiao Road Changning District
Shanghai
China
86 21 5229 3555
https://www.3healthcare.com

版塊Healthcare
行業Biotechnology
全職員工2,158

高階主管

名稱頭銜支付行使價出生年份
Dr. Yongtai HouExecutive Chairman1962
Dr. Jianying WuGM & Executive Director1964
Mr. Minjie TangCFO & Executive Director1975
Ms. Yiyi ChenExecutive Director1982
Ms. Min TianJoint Company Secretary1989
Ms. Caixia RenDeputy General Manager1958
Mr. Ming King Chiu FCIS, FCSJoint Company Secretary1977
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. It also offers sodium hyaluronate injection, medical chitosan, sodium hyaluronate gel, sodium hyaluronate gel, anti adhesion, and burn wound related products. In addition, the company provides injectors, scalpels, and suture needles. Further, it offers medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, the company is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

公司管治

截至 無 止,Shanghai Haohai Biological Technology Co., Ltd. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。